Group 1 - Bristol Gate Capital Partners' Q3 2025 investor letter indicates that the US Equity Strategy underperformed the S&P 500® Total Return Index this quarter but achieved a 15% dividend growth over the trailing 12 months due to strong underlying fundamentals [1] - The underperformance is attributed to limited exposure to the AI/TMT sector and the Value sector, which benefited from the Federal Reserve's rate cut [1] - The fund's top five holdings are highlighted as key picks for 2025 [1] Group 2 - Accenture plc (NYSE:ACN) is noted as a significant stock in the investor letter, with a one-month return of 3.44% and a 52-week decline of 23.25%, closing at $270.00 per share with a market capitalization of $167.438 billion [2] - Accenture was identified as a main detractor in the portfolio due to disappointing results from Gartner, which raised concerns about the impact of GenAI on consulting services [3] - Despite the challenges, Accenture's revenue from advanced AI tripled to $2.7 billion in fiscal 2025, with Gen AI bookings nearly doubling to $5.9 billion, indicating strong growth potential [3]
Do You Believe in the Growth Potential of Accenture (ACN)?